COM:ENOCHIANBIO
Renovaro Biosciences
- Stock
Last Close
0.70
04/08 19:58
Market Cap
45.38M
Beta: -
Volume Today
87.29K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.41M - | -6.58M 36.78% | -6.20M 5.79% | -90.24M 1,355.09% | -7.70M 91.47% | -4.33M - | -23.20M 435.97% | -9.18M 60.45% | -4.53M 50.64% | -17.02M 275.89% | -15.73M 7.59% | -44.21M 181.04% | ||
depreciation and amortization | 100.39K - | 101.16K 0.77% | 101.80K 0.63% | 28.33K 72.17% | 28.40K 0.24% | 28.24K - | 28.01K 0.83% | 27.26K 2.67% | 33.16K 21.65% | 30.30K 8.62% | 116.93K 285.84% | 32.38K 72.30% | ||
deferred income tax | ||||||||||||||
stock based compensation | 1.08M - | 612.88K 43.05% | 983.83K 60.52% | 999.23K 1.57% | 1.86M 86.30% | -3.74M 300.98% | 357.65K 109.56% | |||||||
change in working capital | -592.00K - | -423.51K 28.46% | 584.03K 237.90% | 1.85M 216.18% | 3.33M 80.40% | -158.56K - | 982.99K 719.94% | 628.95K 36.02% | 153.46K 75.60% | 4.33M 2,724.09% | 1.75M 59.65% | |||
accounts receivables | 1.64K - | -46 - | -3.99K 8,569.57% | -1.11M - | ||||||||||
inventory | ||||||||||||||
accounts payables | 227.31K - | -381.12K 267.67% | 320.27K 184.03% | 914.85K 185.65% | 3.28M 258.62% | -83.87K - | 825.47K 1,084.21% | 124.30K 84.94% | 156.79K 26.14% | 1.83M 1,066.60% | 1.95M 6.45% | 1.95M 0.33% | ||
other working capital | -820.95K - | -42.39K 94.84% | 263.76K 722.22% | 931.78K 253.27% | 54.36K 94.17% | 149 99.73% | 148 0.67% | 16.24K - | -1.65K 110.17% | -1.65K 0.06% | 2.86M 173,137.49% | |||
other non cash items | 5.60M - | 2.87M 48.77% | 2.61M 8.86% | 84.45M 3,130.49% | -1.70M 102.01% | 74.62K - | 352.76K 372.73% | 4.64M 1,214.72% | 196.65K 95.76% | -256.11K 230.23% | 15.19M 6,032.63% | 41.81M 175.15% | ||
net cash provided by operating activities | -5.28M - | -4.62M 12.44% | -2.78M 39.73% | -3.05M 9.54% | -2.82M 7.55% | -3.31M - | -2.26M 31.63% | -2.78M 22.80% | -3.15M 13.30% | -2.63M 16.30% | -2.41M 8.35% | -2.02M 16.47% | ||
investments in property plant and equipment | -5.16K - | -23.63K - | -6.14K - | -5.29K - | -23.55K 344.88% | |||||||||
acquisitions net | -65.85K - | |||||||||||||
purchases of investments | ||||||||||||||
sales maturities of investments | ||||||||||||||
other investing activites | -1.06M - | -15.75K 98.51% | -29.82K - | |||||||||||
net cash used for investing activites | -5.16K - | -6.14K - | -1.06M 17,126.43% | -57.33K 94.58% | -91.60K 59.76% | -53.37K 41.73% | ||||||||
debt repayment | -227.60K - | -222.17K 2.39% | -111.08K 50.00% | -466.63K - | -280.77K 39.83% | -562.82K 100.45% | -2.50M 345.08% | -2.29M 8.70% | -4.40M 92.41% | |||||
common stock issued | 130K - | 4.91K - | 1.63M 32,975.51% | 2.48M - | 1.53M 38.43% | 2M 30.82% | 1M - | -1.34M 234.19% | ||||||
common stock repurchased | ||||||||||||||
dividends paid | ||||||||||||||
other financing activites | 3.05M - | 451.70K 85.18% | 1.18M 160.43% | -1.93M - | 2.03M 204.92% | |||||||||
net cash used provided by financing activities | 2.95M - | 229.53K 92.22% | 1.07M 366.25% | 1.63M 51.84% | 2.11M - | 1.25M 40.81% | 2.56M 105.35% | 2.85M 11.08% | 2.64M 7.23% | 2.47M 6.60% | 2.03M 17.74% | |||
effect of forex changes on cash | 28.30K - | -53.86K 290.27% | -78.74K 46.20% | 77.60K 198.55% | 153.08K 97.27% | -91.79K 159.97% | -12.75K 86.11% | |||||||
net change in cash | -5.28M - | -1.67M 68.40% | -2.56M 53.19% | -1.98M 22.61% | -1.20M 39.35% | -1.17M - | -1.07M 8.31% | -1.35M 25.84% | -279.49K 79.31% | 68.72K 124.59% | -92.23K 234.22% | 104 100.11% | ||
cash at beginning of period | 20.66M - | 15.38M 25.57% | 13.71M 10.85% | 11.15M 18.65% | 9.17M 17.75% | 4.12M - | 2.95M 28.43% | 1.87M 36.42% | 523.47K 72.07% | 243.98K 53.39% | 312.70K 28.17% | 220.47K 29.50% | ||
cash at end of period | 15.38M - | 13.71M 10.85% | 11.15M 18.65% | 9.17M 17.75% | 7.97M 13.09% | 2.95M - | 1.87M 36.42% | 523.47K 72.07% | 243.98K 53.39% | 312.70K 28.17% | 220.47K 29.50% | 220.57K 0.05% | ||
operating cash flow | -5.28M - | -4.62M 12.44% | -2.78M 39.73% | -3.05M 9.54% | -2.82M 7.55% | -3.31M - | -2.26M 31.63% | -2.78M 22.80% | -3.15M 13.30% | -2.63M 16.30% | -2.41M 8.35% | -2.02M 16.47% | ||
capital expenditure | -5.16K - | -23.63K - | -6.14K - | -5.29K - | -23.55K 344.88% | |||||||||
free cash flow | -5.28M - | -4.62M 12.52% | -2.78M 39.73% | -3.05M 9.54% | -2.82M 7.55% | -23.63K 99.16% | -3.31M 13,896.50% | -2.27M 31.44% | -2.78M 22.47% | -3.15M 13.30% | -2.64M 16.13% | -2.44M 7.65% | -2.02M 17.27% |
All numbers in USD (except ratios and percentages)